Erythropoietin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury via Inflammasome Suppression in Mice

Acute kidney injury (AKI) is the most common condition in hospitalized patients. As ischemia/reperfusion-induced AKI (IR-AKI) is as a major contributor to end-stage disease, an effective therapeutic intervention for IR-AKI is imperative. Erythropoietin (EPO) is a potent stimulator of erythroid proge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Jihye, Kim, Jin Hyun, Jang, Ha Nee, Jung, Myeong Hee, Cho, Hyun Seop, Chang, Se-Ho, Kim, Hyun-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278975/
https://www.ncbi.nlm.nih.gov/pubmed/32414157
http://dx.doi.org/10.3390/ijms21103453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278975/
https://www.ncbi.nlm.nih.gov/pubmed/32414157
http://dx.doi.org/10.3390/ijms21103453

Ejemplares similares